| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |